115 related articles for article (PubMed ID: 32454786)
1. Time to Treatment Initiation and Survival in Adult Localized High-Grade Bone Sarcoma.
Lawrenz JM; Featherall J; Curtis GL; George J; Jin Y; Anderson PM; Shepard DR; Reith JD; Rubin BP; Nystrom LM; Mesko NW
Sarcoma; 2020; 2020():2984043. PubMed ID: 32454786
[TBL] [Abstract][Full Text] [Related]
2. Time to treatment initiation and survival in adult localized, high-grade soft tissue sarcoma.
Featherall J; Curtis GL; Lawrenz JM; Jin Y; George J; Scott J; Shah C; Shepard D; Rubin BP; Nystrom LM; Mesko NW
J Surg Oncol; 2019 Dec; 120(7):1241-1251. PubMed ID: 31587292
[TBL] [Abstract][Full Text] [Related]
3. Patients with an increased time to treatment initiation have a poorer overall survival after definitive surgery for localized high-grade soft-tissue sarcoma in the extremity or trunk : report from the National Cancer Database.
Ogura K; Fujiwara T; Healey JH
Bone Joint J; 2021 Jun; 103-B(6):1142-1149. PubMed ID: 34058874
[TBL] [Abstract][Full Text] [Related]
4. Adult Primary Bone Sarcoma and Time to Treatment Initiation: An Analysis of the National Cancer Database.
Lawrenz JM; Curtis GL; Styron JF; George J; Anderson PM; Zahler S; Shepard DR; Rubin BP; Nystrom LM; Mesko NW
Sarcoma; 2018; 2018():1728302. PubMed ID: 30533997
[TBL] [Abstract][Full Text] [Related]
5. Adult soft tissue sarcoma and time to treatment initiation: An analysis of the National Cancer Database.
Curtis GL; Lawrenz JM; George J; Styron JF; Scott J; Shah C; Shepard DR; Rubin B; Nystrom LM; Mesko NW
J Surg Oncol; 2018 Jun; 117(8):1776-1785. PubMed ID: 29949654
[TBL] [Abstract][Full Text] [Related]
6. Homogenous and Heterogenous Prognostic Factors for Patients with Bone Sarcoma.
Xu G; Wu H; Xu Y; Zhang Y; Lin F; Baklaushev VP; Chekhonin VP; Peltzer K; Wang X; Mao M; Wang G; Cui P; Zhang C
Orthop Surg; 2021 Feb; 13(1):134-144. PubMed ID: 33305494
[TBL] [Abstract][Full Text] [Related]
7. Survival Impact of Time to Initiation of Adjuvant Radiation for Merkel Cell Carcinoma: An Analysis of the National Cancer Database.
Yusuf M; Gaskins J; Tennant P; Bumpous J; Dunlap N
Pract Radiat Oncol; 2019; 9(4):e372-e385. PubMed ID: 30926480
[TBL] [Abstract][Full Text] [Related]
8. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.
Mukherjee D; Chaichana KL; Gokaslan ZL; Aaronson O; Cheng JS; McGirt MJ
J Neurosurg Spine; 2011 Feb; 14(2):143-50. PubMed ID: 21184634
[TBL] [Abstract][Full Text] [Related]
9. Accuracy of Time to Treatment Initiation Data in Musculoskeletal Soft Tissue Sarcoma.
Lawrenz JM; Vega JF; George J; Curtis GL; Gordon J; Maggiotto A; Tullio K; Shepard DR; Reith JD; Schwartz HS; Nystrom LM; Mesko NW
Sarcoma; 2023; 2023():9022770. PubMed ID: 37261268
[TBL] [Abstract][Full Text] [Related]
10. Increasing time to treatment initiation for head and neck cancer: an analysis of the National Cancer Database.
Murphy CT; Galloway TJ; Handorf EA; Wang L; Mehra R; Flieder DB; Ridge JA
Cancer; 2015 Apr; 121(8):1204-13. PubMed ID: 25490875
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Absolute Lymphocyte Count at Diagnosis and Mortality Among Patients With Localized Bone or Soft Tissue Sarcoma.
Brewster R; Purington N; Henry S; Wood D; Ganjoo K; Bui N
JAMA Netw Open; 2021 Mar; 4(3):e210845. PubMed ID: 33666664
[TBL] [Abstract][Full Text] [Related]
12. No impact of time to treatment initiation for head and neck cancer in a tertiary university center in 2003, 2008 and 2013.
Kouka M; Engelhardt M; Wittig A; Schultze-Mosgau S; Ernst T; Guntinas-Lichius O
Eur Arch Otorhinolaryngol; 2022 Sep; 279(9):4549-4560. PubMed ID: 35488907
[TBL] [Abstract][Full Text] [Related]
13. Longer duration of symptoms at the time of presentation is not associated with worse survival in primary bone sarcoma.
Lawrenz JM; Styron JF; Parry M; Grimer RJ; Mesko NW
Bone Joint J; 2018 May; 100-B(5):652-661. PubMed ID: 29701086
[TBL] [Abstract][Full Text] [Related]
14. Epidemiologic and survival trends in adult primary bone tumors of the spine.
Kerr DL; Dial BL; Lazarides AL; Catanzano AA; Lane WO; Blazer DG; Brigman BE; Mendoza-Lattes S; Eward WC; Erickson ME
Spine J; 2019 Dec; 19(12):1941-1949. PubMed ID: 31306757
[TBL] [Abstract][Full Text] [Related]
15. Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas?
Posch F; Leitner L; Bergovec M; Bezan A; Stotz M; Gerger A; Pichler M; Stöger H; Liegl-Atzwanger B; Leithner A; Szkandera J
Clin Orthop Relat Res; 2017 May; 475(5):1427-1435. PubMed ID: 28083752
[TBL] [Abstract][Full Text] [Related]
16. The Effects of Time to Treatment Initiation for Patients With Non-small-cell Lung Cancer in the United States.
Cushman TR; Jones B; Akhavan D; Rusthoven CG; Verma V; Salgia R; Sedrak M; Massarelli E; Welsh JW; Amini A
Clin Lung Cancer; 2021 Jan; 22(1):e84-e97. PubMed ID: 33039348
[TBL] [Abstract][Full Text] [Related]
17. Benchmarking Time-to-Treatment Initiation in Sarcoma Care Using Real-World-Time Data.
Schärer M; Heesen P; Bode-Lesniewska B; Studer G; Fuchs B;
Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136394
[TBL] [Abstract][Full Text] [Related]
18. Association of Delayed Time to Treatment Initiation With Overall Survival and Recurrence Among Patients With Head and Neck Squamous Cell Carcinoma in an Underserved Urban Population.
Liao DZ; Schlecht NF; Rosenblatt G; Kinkhabwala CM; Leonard JA; Ference RS; Prystowsky MB; Ow TJ; Schiff BA; Smith RV; Mehta V
JAMA Otolaryngol Head Neck Surg; 2019 Nov; 145(11):1001-1009. PubMed ID: 31513264
[TBL] [Abstract][Full Text] [Related]
19. The impact of time to treatment initiation on survival from head and neck cancer in north-eastern Italy.
Polesel J; Furlan C; Birri S; Giacomarra V; Vaccher E; Grando G; Gobitti C; Navarria F; Schioppa O; Minatel E; Bidoli E; Barzan L; Franchin G
Oral Oncol; 2017 Apr; 67():175-182. PubMed ID: 28351574
[TBL] [Abstract][Full Text] [Related]
20. Increasing time to postoperative stereotactic radiation therapy for patients with resected brain metastases: investigating clinical outcomes and identifying predictors associated with time to initiation.
Yusuf MB; Amsbaugh MJ; Burton E; Nelson M; Williams B; Koutourousiou M; Nauta H; Woo S
J Neurooncol; 2018 Feb; 136(3):545-553. PubMed ID: 29143275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
